Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claes Wahlestedt

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Neuromolecular Medicine|June 19, 2009
microRNAs in CNS disordersJannet Kocerha, Sakari Kauppinen, Claes Wahlestedt
Pharmaceutical Patent Analyst|November 19, 2013
Oligonucleotides for upregulating gene expressionOlga Khorkova, Jane Hsiao, Claes Wahlestedt
Biochemical and Biophysical Research Communications|February 16, 2006
No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNACecilia Dahlgren, Claes Wahlestedt, Håkan Thonberg
Oligonucleotides|January 1, 2005
Antisense-induced Fas mRNA degradation produces site-specific stable 3'-mRNA fragment by exonuclease cleavage at the complementary sequenceHåkan Thonberg, Cecilia Dahlgren, Claes Wahlestedt
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2012
RNAi joins the "Singles Club"Veronica J Peschansky, Zicai Liang, Claes Wahlestedt
Trends in Genetics : TIG|April 15, 2015
The Landscape of long noncoding RNA classificationGeorges St Laurent, Claes Wahlestedt, Philipp Kapranov
Genome Research|June 24, 2003
GeneLynx mouse: integrated portal to the mouse genomeBoris Lenhard, Claes Wahlestedt, Wyeth W Wasserman
BMC Bioinformatics|June 1, 2005
Considerations when using the significance analysis of microarrays (SAM) algorithmOla Larsson, Claes Wahlestedt, James A Timmons
BMC Medicine|May 18, 2013
Personalized medicine in psychiatry: problems and promisesUzoezi Ozomaro, Claes Wahlestedt, Charles B Nemeroff
Nature Biotechnology|March 10, 2010
Navigating genomic maps of cancer cellsMarcel P van der Brug, Claes Wahlestedt
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Neuromolecular Medicine|June 19, 2009
microRNAs in CNS disordersJannet Kocerha, Sakari Kauppinen, Claes Wahlestedt
Pharmaceutical Patent Analyst|November 19, 2013
Oligonucleotides for upregulating gene expressionOlga Khorkova, Jane Hsiao, Claes Wahlestedt
Biochemical and Biophysical Research Communications|February 16, 2006
No induction of anti-viral responses in human cell lines HeLa and MCF-7 when transfecting with siRNA or siLNACecilia Dahlgren, Claes Wahlestedt, Håkan Thonberg
Oligonucleotides|January 1, 2005
Antisense-induced Fas mRNA degradation produces site-specific stable 3'-mRNA fragment by exonuclease cleavage at the complementary sequenceHåkan Thonberg, Cecilia Dahlgren, Claes Wahlestedt
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 8, 2012
RNAi joins the "Singles Club"Veronica J Peschansky, Zicai Liang, Claes Wahlestedt
Trends in Genetics : TIG|April 15, 2015
The Landscape of long noncoding RNA classificationGeorges St Laurent, Claes Wahlestedt, Philipp Kapranov
Genome Research|June 24, 2003
GeneLynx mouse: integrated portal to the mouse genomeBoris Lenhard, Claes Wahlestedt, Wyeth W Wasserman
BMC Bioinformatics|June 1, 2005
Considerations when using the significance analysis of microarrays (SAM) algorithmOla Larsson, Claes Wahlestedt, James A Timmons
BMC Medicine|May 18, 2013
Personalized medicine in psychiatry: problems and promisesUzoezi Ozomaro, Claes Wahlestedt, Charles B Nemeroff
Nature Biotechnology|March 10, 2010
Navigating genomic maps of cancer cellsMarcel P van der Brug, Claes Wahlestedt
Pageof 21